Walk the independent claim. Apple's grant US12396686B2, "Sensing health parameters in wearable devices" (issued August 26, 2025; inventors including Wegene Tadele and Maegan Spencer), is a granted patent. Its CPC mix — A61B 5/7203 for diagnostic signal processing, A61B 5/6803 and 5/681 for worn sensors — marks a wearable-sensing-and-analysis claim.
The element that does the work is the sensing arrangement and its processing. The claim is not about inventing a heart-rate sensor or a temperature sensor; it is about how sensors are arranged in a worn device and how their signals are processed to yield health parameters. The defensible work is the integration and the analysis pipeline.
What it reads on is the multi-sensor health subsystem of a smartwatch — the arrangement that turns raw optical, electrical, and motion signals into the health metrics the device reports. Apple's watch is the archetype, and the claim protects a piece of how its sensing-and-analysis stack is built.
Scope discipline: the claim protects the recited sensing arrangement and processing, not health sensing in general and not any individual sensor. A wearable with a materially different sensor arrangement or analysis pipeline may operate outside it. The house rule applies — scope ends where the claim ends, and breadth of the topic does not mean breadth of the claim.
Granted status places US12396686B2 in the dense, actively-litigated wrist-health thicket alongside Samsung, Masimo, Valencell, and others. The wearable-health space is one of the most contested in consumer devices precisely because the integration claims — like this one — are valuable and overlapping.
For a strategist, the patent is one node in Apple's deep wrist-health portfolio, and its framing — the arrangement and processing rather than a single sensor — is the more defensible kind of claim. Reading it precisely, rather than as "Apple patented health sensing," is exactly the discipline the wearable-health space demands.